The RAS rush: Revolution Medicines bags remarkable $238M IPO raise, more than doubling original goal

Revolution Medicines made it.

Less than a month after pencilling in $100 million for its IPO — divulging some details about its foray into the red …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

The RAS rush: Rev­o­lu­tion Med­i­cines bags re­mark­able $238M IPO raise, more than dou­bling orig­i­nal goal